Angiopoietin-2 TIEs up macrophages in tumor angiogenesis
- PMID: 21576085
- DOI: 10.1158/1078-0432.CCR-10-0171
Angiopoietin-2 TIEs up macrophages in tumor angiogenesis
Abstract
Angiopoietin-2 (ANG2), a ligand of the TIE2 receptor, modulates endothelial cell biology and destabilizes blood vessels to facilitate angiogenesis. Recent reports have shown that ANG2 inhibition, for example, by monoclonal antibodies, peptibodies, or CovX-Bodies, may achieve substantial antiangiogenic and antitumor responses in a variety of mouse tumor models, including spontaneous MMTV-PyMT mammary and RIP1-Tag2 pancreatic islet adenocarcinomas. There is also evidence that targeting the ANG2/TIE2 signaling pathway may inhibit the functions of TIE2-expressing macrophages (TEM), a tumor-associated macrophage subset endowed with proangiogenic activity in mouse tumor models. The clinical opportunities afforded by simultaneously targeting the effects of ANG2 on tumor angiogenesis and the proangiogenic activity of TEMs are discussed.
©2011 AACR.
Similar articles
-
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.Cancer Cell. 2011 Apr 12;19(4):512-26. doi: 10.1016/j.ccr.2011.02.005. Cancer Cell. 2011. PMID: 21481792
-
Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth.Clin Cancer Res. 2011 Mar 1;17(5):1001-11. doi: 10.1158/1078-0432.CCR-10-2317. Epub 2011 Jan 13. Clin Cancer Res. 2011. PMID: 21233403
-
MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.Int J Oncol. 2012 May;40(5):1321-30. doi: 10.3892/ijo.2012.1366. Epub 2012 Feb 10. Int J Oncol. 2012. PMID: 22327175
-
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.Cells. 2019 May 17;8(5):471. doi: 10.3390/cells8050471. Cells. 2019. PMID: 31108880 Free PMC article. Review.
-
Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2.Cancer Res. 2007 Sep 15;67(18):8429-32. doi: 10.1158/0008-5472.CAN-07-1684. Cancer Res. 2007. PMID: 17875679 Review.
Cited by
-
Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617.Microvasc Res. 2012 May;83(3):290-7. doi: 10.1016/j.mvr.2012.02.008. Epub 2012 Feb 23. Microvasc Res. 2012. PMID: 22387475 Free PMC article.
-
Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer.EMBO Mol Med. 2021 Jul 7;13(7):e08253. doi: 10.15252/emmm.201708253. Epub 2021 Jun 14. EMBO Mol Med. 2021. PMID: 34125494 Free PMC article. Review.
-
Endometriosis, a disease of the macrophage.Front Immunol. 2013 Jan 28;4:9. doi: 10.3389/fimmu.2013.00009. eCollection 2013. Front Immunol. 2013. PMID: 23372570 Free PMC article.
-
7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.MAbs. 2012 Mar-Apr;4(2):134-52. doi: 10.4161/mabs.4.2.19426. Epub 2012 Mar 1. MAbs. 2012. PMID: 22453093 Free PMC article.
-
Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.Exp Suppl. 2022;113:107-140. doi: 10.1007/978-3-030-91311-3_4. Exp Suppl. 2022. PMID: 35165862
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
